SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek - Quaterly Results

12 Nov 2024 Evaluate
The sales surged to Rs. 0.58 millions, up 28.89% for the September 2024 quarter as against Rs. 0.45 millions during the corresponding quarter previous year.The Net Loss for the quarter ended September 2024 is Rs. -0.73 millions as compared to Net Loss of Rs. -1.32 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -0.33% as compared to -0.77% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 0.58 0.45 28.89 1.07 1.45 -26.21 2.35 0.55 327.27
Other Income 0.44 0.44 0.00 6.96 0.88 690.91 1.83 1.75 4.57
PBIDT -0.33 -0.77 -57.14 2.07 -1.53 -235.29 -4.34 -8.77 -50.51
Interest 0.17 0.32 -46.88 0.34 0.64 -46.88 1.29 1.81 -28.73
PBDT -0.50 -1.09 -54.13 1.73 -2.17 -179.72 -5.63 -10.58 -46.79
Depreciation 0.23 0.23 0.00 0.46 0.46 0.00 0.92 49.50 -98.14
PBT -0.73 -1.32 -44.70 1.27 -2.63 -148.29 -6.55 -60.08 -89.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.73 -1.32 -44.70 1.27 -2.63 -148.29 -6.55 -60.08 -89.10
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) -56.90 -171.11 -66.75 193.46 -105.52 -283.34 -184.68 -1594.55 -88.42

Transgene Biotek Share Price

3.09 -0.01 (-0.32%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.55
Indegene 482.65
CMS Info Systems 317.60
JITF Infralogistics 331.25
Sagility 42.17
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×